| |
| |
|
| Insider
Information: |
Mckenzie Paul |
| Relationship: |
EVP Pharmaceutical Ope... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
7,235 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,559,143 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
7,235 |
|
|
| Total
Value |
$1,559,143 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biogen Idec Inc |
BIIB |
EVP Pharmaceutical Ope... |
2019-03-01 |
7,235 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BIIB |
Biogen Idec Inc |
EVP Pharmaceutical Oper & Tech |
• • – |
2019-03-01 |
4 |
D |
$334.10 |
$219,838 |
D/D |
(658) |
7,235 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Pharmaceutical Oper & Tech |
• • – |
2019-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
568 |
7,488 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Pharmaceutical Oper & Tech |
• • – |
2019-02-15 |
4 |
D |
$332.87 |
$214,035 |
D/D |
(643) |
7,325 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Pharmaceutical Oper & Tech |
• • – |
2019-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,448 |
7,968 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Pharmaceutical Oper & Tech |
• • – |
2019-02-12 |
4 |
D |
$319.43 |
$293,556 |
D/D |
(919) |
6,520 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Pharmaceutical Oper & Tech |
• • – |
2019-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,062 |
7,059 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Pharmaceutical Oper & Tech |
• • – |
2018-03-01 |
4 |
D |
$282.35 |
$181,269 |
D/D |
(642) |
4,302 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Pharmaceutical Oper & Tech |
• • – |
2018-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
532 |
4,539 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Pharmaceutical Oper & Tech |
• • – |
2018-02-15 |
4 |
D |
$299.38 |
$132,326 |
D/D |
(442) |
4,412 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Pharmaceutical Oper & Tech |
• • – |
2018-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,472 |
4,854 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Pharmaceutical Oper & Tech |
• • – |
2017-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,730 |
3,291 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Pharmaceutical Oper & Tech |
• • – |
2017-03-01 |
4 |
D |
$293.26 |
$46,042 |
D/D |
(157) |
561 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Pharmaceutical Oper & Tech |
• • – |
2017-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
481 |
718 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Pharmaceutical Oper & Tech |
• – – |
2016-07-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
210 |
|
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
